300 related articles for article (PubMed ID: 35202526)
1. Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.
Hasan T; Nguyen VN; Nguyen HB; Nguyen TA; Le HTT; Pham CD; Hoang N; Nguyen PTM; Beardsley J; Marks GB; Fox GJ
Emerg Infect Dis; 2022 Mar; 28(3):684-692. PubMed ID: 35202526
[TBL] [Abstract][Full Text] [Related]
2. Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.
Soko RN; Burke RM; Feasey HRA; Sibande W; Nliwasa M; Henrion MYR; Khundi M; Dodd PJ; Ku CC; Kawalazira G; Choko AT; Divala TH; Corbett EL; MacPherson P
Emerg Infect Dis; 2021 Jul; 27(7):1831-1839. PubMed ID: 34152962
[TBL] [Abstract][Full Text] [Related]
3. Digital health solutions and integrated COVID-19 and TB services to help recover TB care and prevention services in the COVID-19 pandemic: A descriptive study in four high TB burden countries.
Spruijt I; Alam Y; Nguyen H; Myrzaliev B; Ahmatov M; Odume B; Mtei L; Gebhard A; Gidado M; Jerene D
PLoS One; 2023; 18(11):e0293964. PubMed ID: 37983209
[TBL] [Abstract][Full Text] [Related]
4. Impact of COVID-19 on tuberculosis notifications.
Pontes TAA; Fernandez-Llimos F; Wiens A
Rev Inst Med Trop Sao Paulo; 2024; 66():e37. PubMed ID: 38865575
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of multidrug-resistant tuberculosis case notifications in Australia (1999-2018).
Camphor HS; Viney K; Polkinghorne B; Pennington K
Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829704
[TBL] [Abstract][Full Text] [Related]
6. Early COVID-19 pandemic's toll on tuberculosis services, WHO European Region, January to June 2020.
Dara M; Kuchukhidze G; Yedilbayev A; Perehinets I; Schmidt T; Van Grinsven WL; Boeree MJ
Euro Surveill; 2021 Jun; 26(24):. PubMed ID: 34142649
[TBL] [Abstract][Full Text] [Related]
7. Interrupted time-series analysis of active case-finding for tuberculosis during the COVID-19 pandemic, Zambia.
Lungu PS; Kerkhoff AD; Muyoyeta M; Kasapo CC; Nyangu S; Kagujje M; Chimzizi R; Nyimbili S; Khunga M; Kasese-Chanda N; Musonda V; Tambatamba B; Kombe CM; Sakulanda C; Sampa K; Silumesii A; Malama K
Bull World Health Organ; 2022 Mar; 100(3):205-215. PubMed ID: 35261409
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis notifications in Australia, 2014.
Toms C; Stapledon R; Coulter C; Douglas P
Commun Dis Intell Q Rep; 2017 Sep; 41(3):E247-E263. PubMed ID: 29720074
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and tuberculosis: the double whammy of respiratory pathogens.
Shariq M; Sheikh JA; Quadir N; Sharma N; Hasnain SE; Ehtesham NZ
Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35418488
[TBL] [Abstract][Full Text] [Related]
10. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
Homolka S; Paulowski L; Andres S; Hillemann D; Jou R; Günther G; Claassens M; Kuhns M; Niemann S; Maurer FP
Emerg Infect Dis; 2020 Nov; 26(11):2549-2554. PubMed ID: 32956612
[TBL] [Abstract][Full Text] [Related]
11. Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries.
McQuaid CF; Henrion MYR; Burke RM; MacPherson P; Nzawa-Soko R; Horton KC
BMC Med; 2022 Nov; 20(1):432. PubMed ID: 36372899
[TBL] [Abstract][Full Text] [Related]
12. Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002-2008.
van Halsema CL; Fielding KL; Chihota VN; Lewis JJ; Churchyard GJ; Grant AD
Int J Tuberc Lung Dis; 2012 Jul; 16(7):967-73. PubMed ID: 22584100
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
Judge D; Krause V
Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
[TBL] [Abstract][Full Text] [Related]
14. The Impact of the COVID-19 Pandemic on Tuberculosis Case Notification and Treatment Outcomes in Eswatini.
Masina HV; Lin IF; Chien LY
Int J Public Health; 2022; 67():1605225. PubMed ID: 36387290
[No Abstract] [Full Text] [Related]
15. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
Park S; Jo KW; Lee SD; Kim WS; Shim TS
Respir Med; 2017 Oct; 131():43-48. PubMed ID: 28947041
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis in pregnancy.
Hui SYA; Lao TT
Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt A):34-44. PubMed ID: 36002371
[TBL] [Abstract][Full Text] [Related]
17. Psychometric evaluation of a new drug-resistant tuberculosis stigma scale.
Redwood L; Mitchell EMH; Nguyen TA; Viney K; Nguyen VN; Fox GJ
J Clin Epidemiol; 2021 May; 133():101-110. PubMed ID: 33476766
[TBL] [Abstract][Full Text] [Related]
18. Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape.
Monedero-Recuero I; Gegia M; Wares DF; Chadha SS; Mirzayev F
Int J Infect Dis; 2021 Jul; 108():557-567. PubMed ID: 34139370
[TBL] [Abstract][Full Text] [Related]
19. Ending TB: the world's oldest pandemic.
Kim PS; Swaminathan S
J Int AIDS Soc; 2021 Mar; 24(3):e25698. PubMed ID: 33754449
[No Abstract] [Full Text] [Related]
20. Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study.
Chaves-Torres NM; Fadul S; Patiño J; Netto E
PLoS One; 2021; 16(4):e0249565. PubMed ID: 33852619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
